
    
      PRIMARY OBJECTIVES:

      I. To determine the dose and schedule of the combination of palbociclib and dexamethasone in
      patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia (ALL).

      ii. To determine the safety and tolerability of the combination of palbociclib and
      dexamethasone in patients with relapsed or refractory adult B-cell ALL.

      SECONDARY OBJECTIVES:

      I. To evaluate the activity of palbociclib in combination with dexamethasone in patients with
      relapsed or refractory B-cell ALL.
    
  